At Advanced Infusion Care, a division of AIS Healthcare, we apply a team approach to intravenous (IV) and subcutaneous (SubQ) immunoglobulin therapy patient care. Collaboration between physicians and the nationally accredited AIC home infusion team ensures the consistent delivery of patient-specific, specialized in-home infusion services to patients across the country, helping to improve outcomes—and lives.
Every AIC patient has 24/7 access to a dedicated team of clinical and support staff, including:
AIC is contracted with multiple Ig suppliers for long-term supply agreements to help guarantee product availability and onboard more patients.
We are a limited pharmacy distribution partner for Grifols’ new 20% subcutaneous Ig therapy, Xembify®.
Learn more at grifols.com.
Dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), AIC is regularly inspected by national and state boards of pharmacy and is a member of the Immunoglobulin National Society (IgNS).
For providers, AIC is a partner in patient management, including patient onboarding and seamless transitions to IV treatment in the clinic or in the patient’s home. We work with patients, insurance companies and office staff to secure all needed authorizations and complete clinical paperwork.